基本信息
浏览量:14
职业迁徙
个人简介
Some psychostimulants of abuse can cause persistent damage to dopaminergic and/or serotonergic neurons in rodents, non-human primates and humans. For example, methamphetamine administration causes persistent dopaminergic deficits that, in part, resemble deficits occurring in Parkinson's disease. Dr. Fleckenstein's laboratory investigates receptor-mediated and subcellular mechanisms contributing to these deficits. A particular focus of the laboratory involves investigating the effects of stimulants on monoaminergic transporters, both because of relevance to the neurotoxicity of stimulants, and because of the laboratory's ongoing interest in the abuse liability of these agents.
A variety of techniques are employed in Dr. Fleckenstein's laboratory including radioligand binding, monoamine uptake assays, western blotting, autoradiography, and high performance liquid chromatography to assess alterations in monoaminergic neuronal function after both non-contingent, and more recently, contingent drug administration.
Ongoing projects involve investigating the impact of synthetic cathinones on monoaminergic neuronal function and behavior. Also of interest are mechanisms underlying the neuroprotective effects of nicotinic receptor activation. Finally, using the Utah Population Data Base Dr. Fleckenstein and colleagues (Curtin et al., Neuropsychopharmacology, 2018) recently reported that individuals with attention deficit disorder are more likely to develop Parkinson's disease: preclinical studies to determine mechanisms underlying this vulnerability are planned."
A variety of techniques are employed in Dr. Fleckenstein's laboratory including radioligand binding, monoamine uptake assays, western blotting, autoradiography, and high performance liquid chromatography to assess alterations in monoaminergic neuronal function after both non-contingent, and more recently, contingent drug administration.
Ongoing projects involve investigating the impact of synthetic cathinones on monoaminergic neuronal function and behavior. Also of interest are mechanisms underlying the neuroprotective effects of nicotinic receptor activation. Finally, using the Utah Population Data Base Dr. Fleckenstein and colleagues (Curtin et al., Neuropsychopharmacology, 2018) recently reported that individuals with attention deficit disorder are more likely to develop Parkinson's disease: preclinical studies to determine mechanisms underlying this vulnerability are planned."
研究兴趣
论文共 112 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Neuropsychopharmacologyno. 6 (2024): 1-1
Behavioural Pharmacologyno. 5 (2016): 422-430
Sergios Charntikov,Natashia Swalve,Steven T. Pittenger, K. Fink, Scott T. Schepers,Gregory C. Hadlock,Annette E. Fleckenstein,Gang Hu,Ming Li,Rick A. Bevins
Neuropharmacology (2016): 590
Ashley N Fricks-Gleason,Christopher L German,Amanda J Hoonakker,Danielle M Friend, Kamala K Ganesh, Aaron S Carver,Glen R Hanson,Annette E Fleckenstein,Kristen A Keefe
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn